Jason Philip Raleigh - Net Worth and Insider Trading

Jason Philip Raleigh Net Worth

The estimated net worth of Jason Philip Raleigh is at least $0 dollars as of 2024-06-09. Jason Philip Raleigh is the Interim CFO and Treasurer of NovaBay Pharmaceuticals Inc and owns about 0 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $0. Details can be seen in Jason Philip Raleigh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Philip Raleigh has not made any transactions after 2019-06-11 and currently still holds the listed stock(s).

Transaction Summary of Jason Philip Raleigh

To

Jason Philip Raleigh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Philip Raleigh owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of Jason Philip Raleigh’s form 4 insider trades.

Insider Ownership Summary of Jason Philip Raleigh

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2019-06-11 Interim CFO and Treasurer

Jason Philip Raleigh Latest Holdings Summary

Jason Philip Raleigh currently owns a total of 1 stock. Jason Philip Raleigh owns 0 shares of NovaBay Pharmaceuticals Inc (NBY) as of June 11, 2019, with a value of $0.

Latest Holdings of Jason Philip Raleigh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBY NovaBay Pharmaceuticals Inc 2019-06-11 0 2.71 0

Holding Weightings of Jason Philip Raleigh


Jason Philip Raleigh Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Philip Raleigh has made a total of 1 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NovaBay Pharmaceuticals Inc is the sale of 27 shares on June 11, 2019, which brought Jason Philip Raleigh around $106,759.

Insider Trading History of Jason Philip Raleigh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Philip Raleigh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jason Philip Raleigh Ownership Network

Ownership Network List of Jason Philip Raleigh

No Data

Ownership Network Relation of Jason Philip Raleigh

Insider Network Chart

Jason Philip Raleigh Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Jason Philip Raleigh is the Interim CFO and Treasurer of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Jason Philip Raleigh Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Philip Raleigh. You might contact Jason Philip Raleigh via mailing address: 2000 Powell Street, Suite 1150, Emeryville Ca 94608.

Discussions on Jason Philip Raleigh

No discussions yet.